AbbVie, Inc.
(NYSE : ABBV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
2.59%139.650.6%$670.28m
ABBVAbbVie, Inc.
1.53%92.442.1%$570.88m
PFEPfizer Inc.
-0.47%35.810.8%$552.37m
MRKMerck & Co., Inc.
-0.41%63.080.6%$455.76m
BMYBristol-Myers Squibb Company
0.60%64.031.4%$327.98m
LLYEli Lilly and Company
0.33%86.231.0%$260.56m
AZNAstraZeneca PLC Sponsored ADR
-0.14%34.601.3%$151.97m
GSKGlaxoSmithKline plc Sponsored ADR
-0.53%40.650.2%$151.16m
NVSNovartis AG Sponsored ADR
-0.45%85.980.2%$133.86m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.07%49.290.1%$106.70m
SNYSanofi Sponsored ADR
-0.75%49.260.2%$57.25m
LCILannett Company, Inc.
-0.47%23.5938.6%$20.40m
AKTXAkari Therapeutics Plc Sponsored ADR
0.31%6.502.2%$6.63m
SCMPSucampo Pharmaceuticals, Inc. Class A
2.75%10.2814.4%$5.37m
EPIXESSA Pharma Inc
-1.99%0.290.0%$0.03m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company. It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products. The company focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.